Show
Sort by
-
- Journal Article
- A1
- open access
The long non-coding RNA landscape in juvenile myelomonocytic leukemia
-
- Journal Article
- A1
- open access
Prolonged versus standard native E-coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma : final results of the EORTC-CLG randomized phase III trial 58951
-
Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials
-
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia
-
LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19
-
Genetic characterization and therapeutic targeting of MYC translocated pediatric T-cell acute lymphoblastic leukemia
-
Impact of age and treatment group in childhood high hyperdiploid low risk B-cell acute lymphoblastic leukemia (ALL) : results of the CLG-EORTC 58951 study
-
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
-
- Journal Article
- A1
- open access
CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol
-
Dexamethasone (6 mg/m²/day) and prednisolone (60 mg/m²/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial